News
Latest News
Contact Us
Novel MSC-based therapy provides hope for ocular GVHD treatment
07/03/2025
News Medical Life Sciences, February 10, 2025 Graft-versus-host disease (GVHD) is a common and severe complication that occurs after stem cell transplantation, where the donor’s
Cerebral Palsy Response to Cell Therapy as a Function of Time
04/03/2025
Parent’s Guide to Cord Blood, 02/2025 For the first time ever, the response of children with cerebral palsy to one cell therapy versus another has
‘Breakthrough’ stem-cell patches strengthened a woman’s failing heart
27/02/2025
Nature, January 29, 2025 Grafting patches of lab-grown muscle to the surface of the heart could offer a lifeline for people waiting for a transplant.
Innovative respiratory organoids help researchers culture previously uncultivable human rhinovirus C
20/02/2025
Medical Express, January 14, 2025 CYT387 enabled serial propagation of HRV-C in human airway organoids. Credit: Nature Communications (2024). DOI: 10.1038/s41467-024-55076-2 A research team has
Molecular bridges can make potent NK cell therapies for lymphoma
17/02/2025
Drug Discovery News, Jan 10, 2025 New data show that NK cell engagers may provide a robust alternative to T cell therapies. In the race
Tongue cancer organoids reveal secrets of chemotherapy resistance
13/02/2025
Science Daily, January 9, 2025 A novel patient-derived organoid library helps researchers identify promising drug targets, including autophagy and cholesterol synthesis pathways Tongue cancer (TC)
Cartistem® Cord Blood-Derived Therapy for Knee Arthritis
11/02/2025
Parent’s Guide to Cord Blood, January, 2025 Medipost is a South Korean company that has developed a pipeline of cell therapy products in which the
Hope for the treatment of alzheimer’s disease may lie in umbilical cord stem cells
22/01/2025
The Portugal News, December 20, 2024 Alzheimer’s disease (AD) is a degenerative neurological condition that affects millions of people around the world. It is characterised
FDA Approves First Mesenchymal Stromal Cell Therapy to Treat Steroid-refractory Acute Graft-versus-host Disease
20/01/2025
FDA News, December 18, 2024 Today, the U.S. Food and Drug Administration approved Ryoncil (remestemcel-L-rknd), an allogeneic (donor) bone marrow-derived mesenchymal stromal cell (MSC) therapy
Autologous cord-blood-derived cell administration in extremely preterm infants
17/01/2025
Medical Express, December 16, 2024 Australian researchers have discovered a potential new lifeline for the tiniest and most vulnerable newborns. Scientists at Monash Children’s Hospital
